Technical Description The technology relates to a gold nanoparticle polymer composite. The composite is useful for space filler material applications, and biocompatible 3D scaffolds. Problems Addressed Time-Taking Process Use of Organic Solvent Complicated Procedure Limitations of Existing Techniques Tech Features…
Technical Description The technology relates to a ceramic foam utilizing red mud as industrial waste. It is highly porous with improved mechanical strength and can be shaped for various applications. Problems Addressed Expensive Complex Process Requires More Constituent Industrial Waste…
Technical Description The technology relates to a system for generation of traffic report for micro or meso-spatial area using data from crowdsource data, sensor, or both. Problems Addressed Low Accuracy No Traffic Report Generation No Traffic Related Parameters Generation Improper…
Technical Description The present invention provides a novel compound 2-(4-Bromophenyl)-5-(4-(pyridin-2-yl) 5 piperazin-1-yl)-1,3,4-oxadiazole which has multi-functional potential against Alzheimer’s disease. Problems Addressed Aβ Accumulation in Brain Limitations of Existing Treatments Poor Drug Efficacy No Multitargeted Molecules Tech Features Novel Compound Multitargeted…
Technical Description The present invention provides N-(1- benzylpiperidin-4-yl)-5-(4-(trifluoromethyl) phenyl)-1,3,4-oxadiazol-2-amine as a multitargeted ligand to treat neurodegenerative disease. Problems Addressed Aβ Accumulation in Brain Limitations of Existing Treatments Monofunctional Molecules Tech Features Novel Compound Multitargeted Ligand Inhibits Cholinesterases & BACE-1 No…
Technical Description The present invention provides a multifunctional compound 2-(2,4-difluorophenyl)-5-(4-(pyridin-2-yl) piperazin-1-yl)-1,3,4-oxadiazole, which has multi-functional potential for treating Alzheimer’s disease. Problems Addressed Aβ Accumulation in Brain Limitations of Existing Treatments Poor Drug Efficacy Tech Features High Bioavailability Inhibits Cholinesterases & BACE-1…
Technical Description The present invention provides a novel multifunctional hybrid molecule for the treatment of neurodegenerative diseases. It is a hybrid of N-benzylpiperidine and 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole for the treatment of Alzheimer’s disease Problems Addressed Aβ Accumulation in Brain Decreased Cholinergic Activity…
Technical Description The technology relates to a thin film transistor having a gate interface between a gate insulating layer and gate electrode to improve the properties of transistors. Problems Addressed High operating voltage Not used in low power Devices Low…
Technical Description The present invention provides the synthesis of novel quinolinyl piperazine derivatives for the treatment of Alzheimer’s disease by dual inhibition of β-secretase (BACE1) and acetylcholineesterase (AChE). Problems Addressed Aβ Accumulation in Brain Single Target Therapy Current Treatment Limitations…
Technical Description The present invention offers a novel bioink for 3D bioprinting, made from two biopolymers and a crosslinking agent in an aqueous solution. Problems Addressed High Cost Time-Consuming Complex Psyllium Extraction Processes Limited Cell-Adhesion Capability Tech Features Better Compressive…
Subscribe to Our Latest Updates!